Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -107.61M | -106.93M | -49.59M | -68.20M | -58.28M |
| Total Depreciation and Amortization | 53.00K | 53.00K | 53.00K | 50.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.05M | 69.86M | 16.44M | 36.11M | 26.48M |
| Change in Net Operating Assets | 1.84M | -1.96M | -2.15M | -817.00K | -74.00K |
| Cash from Operations | -40.67M | -38.99M | -35.25M | -32.86M | -31.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 1.21M | 1.21M |
| Cash from Investing | -- | -- | -- | 1.21M | 1.21M |
| Total Debt Issued | 35.00M | 1.00M | 1.00M | 1.00M | 1.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 39.70M | 32.55M | 35.96M | 11.63M | 6.85M |
| Repurchase of Common Stock | -149.00K | -149.00K | -152.00K | -73.00K | -73.00K |
| Issuance of Preferred Stock | 25.00M | 25.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.40M | -1.25M | 13.22M | 13.27M | 13.86M |
| Cash from Financing | 97.15M | 57.15M | 50.02M | 25.83M | 21.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.48M | 18.17M | 14.77M | -5.82M | -8.98M |